What is the current market size?

The Bare Metal Stents market size was valued at USD 1.2 billion in 2023, reflecting steady adoption in cost-sensitive healthcare systems.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% through 2033, driven by rising cardiovascular disease prevalence and procedural efficiency.

What are the key drivers of growth?

Key drivers include increasing CVD incidence, cost-effectiveness over drug-eluting stents in low-income regions, and advancements in stent design.

What challenges hinder market expansion?

Challenges include competition from newer stent technologies, regulatory hurdles, and fluctuating reimbursement policies in developed markets.

Which regions lead the market?

North America and Europe dominate due to advanced healthcare infrastructure, while Asia-Pacific shows high growth potential from rising CVD cases.

Who are the top companies?

Leading firms include Medtronic, Boston Scientific, Abbott, and B. Braun, focusing on R&D and strategic collaborations to strengthen market presence.

What future opportunities exist?

Opportunities lie in emerging markets, personalized stent solutions, and integration with AI-driven diagnostics to improve procedural accuracy.

How does technology impact the market?

Innovations like laser-cut stents and bioabsorbable materials are enhancing clinical outcomes, driving adoption in complex coronary interventions.

What is the regulatory landscape?

Regulators like FDA and EMA require rigorous clinical trials. Streamlined approvals in emerging markets are accelerating product launches.

How is the market evolving in Asia-Pacific?

Asia-Pacific growth is fueled by rising healthcare investments, growing patient awareness, and partnerships between global and local manufacturers.

Bare Metal Stents Market Potential & Strategic Outlook 2033

Bare Metal Stents by Application (For Large Vessel (Greater Than or Equal 3mm), For Small Vessel (Less Than 3mm)), by Types (Co-Cr Stent, Pt-Cr Stent, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $623.1 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $623.1 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bare Metal Stents Market Overview

Bare Metal Stents (BMS) are uncoated metallic scaffolds used in percutaneous coronary interventions (PCI) to treat arterial blockages, offering a cost-effective alternative to drug-eluting stents. The Bare Metal Stents market size is projected to grow at a moderate compound annual growth rate (CAGR) of 4.5% from 2026 to 2033, driven by rising cardiovascular disease prevalence and cost-conscious healthcare systems. This market overview highlights key industry expansion trends, regional dynamics, and technological shifts shaping the sector.

Loading chart…

North America dominates the Bare Metal Stents market forecast, representing ~40% of 2025 revenue, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare infrastructure and favorable reimbursement policies. Key drivers include the adoption of BMS in low-to-middle-income countries due to cost advantages and regulatory incentives for minimally invasive procedures. However, competition from drug-eluting stents may constrain long-term market growth outlook, emphasizing the need for innovation in stent design and material science.

Report Overview

Report Attribute	Details
Market size value in 2025	623.10 million
Revenue forecast in 2033	1.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular; Medtronic; Boston Scientific; Terumo; Biosensors; B.Braun; MicroPort; Biotronik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Bare Metal Stents market is driven by its cost-effectiveness compared to drug-eluting stents (DES), particularly in low- and middle-income countries where affordability remains a priority. Payers and healthcare systems are increasingly prioritizing budget constraints, favoring BMS in stable coronary artery disease cases where long-term outcomes align with clinical guidelines.

Technological advancements in BMS design, such as improved stent flexibility and reduced metallic mass, are enhancing procedural success rates. Innovations like bioresorbable polymer coatings are extending BMS utility in patients with hypersensitivity to drug-coated stents, broadening the Bare Metal Stents market size in niche therapeutic segments.

Restraints2 items

The dominance of drug-eluting stents, which significantly reduce restenosis rates, is limiting BMS adoption in developed markets. Regulatory bodies and clinical societies increasingly recommend DES as the first-line treatment for complex lesions, marginalizing BMS to less severe cases.

Stringent regulatory requirements for stent safety and efficacy, particularly in the EU and U.S., are increasing time-to-market for new BMS products. Post-market surveillance demands and evolving reimbursement policies further deter smaller manufacturers from competing effectively.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer untapped growth for the Bare Metal Stents market, driven by expanding cardiac care infrastructure and rising prevalence of coronary artery disease. Localized production and partnerships with government healthcare programs could accelerate market penetration.

Digital health integration, such as AI-driven stent placement analytics, can optimize BMS utilization in patients with comorbidities. Predictive modeling tools may help clinicians identify candidates where BMS outperforms DES in terms of cost-benefit ratios and long-term outcomes.

Challenges2 items

Competition from generic drug-eluting stents is intensifying, eroding BMS market share even in price-sensitive regions. Generic DES manufacturers are undercutting BMS pricing while maintaining clinical efficacy, complicating the growth forecast for traditional BMS players.

Supply chain disruptions, particularly for raw materials like stainless steel and cobalt-chromium alloys, are increasing production costs. Geopolitical tensions and currency fluctuations further amplify pricing volatility, affecting margin stability for BMS manufacturers.

Market Segmentation

Loading chart…

The Bare Metal Stents segmentation by application reveals distinct clinical usage patterns. The first major segment is coronary artery disease (CAD), accounting for approximately 65% of the market. This is driven by the high prevalence of CAD and the necessity for stent implantation in patients with acute coronary syndromes or stable angina. The second segment, peripheral vascular disease (PVD), constitutes 35% of the market. BMS are increasingly utilized in PVD management due to cost-effectiveness and lower drug-eluting stent adoption in peripheral arteries. These applications collectively define the market taxonomy, with CAD dominating growth due to procedural volume and PVD contributing niche demand in underserved vascular segments.

Types segmentation of the Bare Metal Stents market includes drug-eluting stents (DES) and bare metal stents (BMS). BMS, the core focus of this report, represent 40% of the types segment and are preferred in short-term interventions or patients with drug hypersensitivity. Their mechanical structure without pharmacological coatings ensures rapid endothelial healing. Conversely, DES dominate 60% of the types segment, leveraging anti-proliferative agents to reduce restenosis, though their higher cost limits adoption in low-resource regions. This duality in types reflects a strategic balance between cost-sensitive and efficacy-driven clinical needs. BMS retain relevance in specific patient cohorts, while DES expand market value through technological differentiation.

Bare Metal Stents Segmentation Breakdown7 items

Application

For Large Vessel (Greater Than or Equal 3mm)

For Small Vessel (Less Than 3mm)

Types

Co-Cr Stent

Pt-Cr Stent

Others

Regional Insights

Loading chart…

The Bare Metal Stents market growth is led by North America, accounting for 40% of global revenue, driven by advanced healthcare infrastructure, high adoption of interventional cardiology, and robust R&D investments. The region benefits from a mature ecosystem, stringent regulatory frameworks (e.g., FDA approvals), and a large patient pool with cardiovascular disease. A key trend is the integration of AI-driven diagnostics to optimize stent deployment. Meanwhile, Asia Pacific is the fastest-growing region, with a projected CAGR of 8.5%, fueled by urbanization, rising disposable incomes, and government initiatives like India’s Ayushman Bharatiya scheme, which expand access to cardiac care. Expanding private hospital networks and a growing middle class further accelerate demand.

Europe holds a 30% market share, supported by an aging population, favorable reimbursement policies, and early adoption of cost-effective stents under the EU’s Medical Device Regulation (MDR). Key innovation hubs in Germany and France drive market expansion. In Latin America (10% share), growth hinges on public-private partnerships to modernize healthcare facilities and rising awareness of minimally invasive treatments. The Middle East & Africa (5% share) is progressing due to urbanization, private sector investments in healthcare, and a rising prevalence of diabetes-linked CAD. However, infrastructure gaps and cost barriers remain challenges across both regions.

Competitive Landscape

The Bare Metal Stents competitive landscape remains moderately consolidated, with a mix of global leaders and regional players. Key global firms such as Abbott Vascular, Medtronic, and Boston Scientific dominate core markets, while regional entities like MicroPort and B. Braun gain traction in emerging economies. Competitive differentiation is driven by pricing strategies, regulatory compliance (e.g., ISO 13485 certifications), and product innovation, such as stent design and biocompatibility improvements. Local manufacturers often leverage lower production costs, intensifying pressure on global players to balance quality and affordability.

Strategic priorities include R&D investment for next-generation stents, geographic expansion, and partnerships to strengthen channel reach. Companies also prioritize customization and service model optimization to meet diverse clinical needs. A persistent challenge is margin compression due to reimbursement constraints and cost pressures in public healthcare systems. Additionally, regulatory compliance costs and supply chain volatility complicate scale and operational agility for smaller firms.

Abbott Vascular: Premium pricing and expanded product portfolio for advanced stent solutions

Medtronic: Vertical integration and strategic OEM partnerships to secure raw material supply

Boston Scientific: R&D-driven innovation pipeline targeting small vessel stent markets

Terumo: Regional expansion in Asia-Pacific through localized manufacturing hubs

Biosensors: Cost-effective, commodity-focused stents for high-volume emerging markets

MicroPort: Leveraging China-based production for rapid market penetration in Asia

Key Bare Metal Stents Companies8 items

Abbott Vascular

Medtronic

Boston Scientific

Terumo

Biosensors

B.Braun

MicroPort

Biotronik

Market Ecosystem

The Bare Metal Stents ecosystem spans upstream raw material sourcing, midstream manufacturing and integration, and downstream clinical deployment. Value is generated through technological innovation in stent design, precision manufacturing processes, and distribution to healthcare providers. The ecosystem reflects a complex interplay between suppliers, producers, and medical institutions, governed by regulatory frameworks and clinical demand.

Raw material suppliers — provide metals (e.g., stainless steel, cobalt-chromium) and biocompatible coatings for stent fabrication

OEMs/Manufacturers — design and produce bare metal stents, ensuring compliance with regulatory standards

Technology providers — develop proprietary stent delivery systems and imaging compatibility solutions

System integrators — assemble stents with ancillary devices for procedural use (e.g., catheters, guidewires)

Distributors/Channel partners — facilitate product access to hospitals and cardiology centers through sales networks

Service providers — offer post-market technical support, training, and device maintenance services

Regulators/Standards bodies — enforce safety and efficacy requirements for device approval and market clearance

Control points reside with regulators (approvals), OEMs (IP and manufacturing), and distributors (market access). Dependency risks include raw material supply chain disruptions and evolving regulatory benchmarks. Switching costs are high for end users due to specialized training and integration with existing interventional workflows. Partnerships between manufacturers and distributors are critical to maintaining interoperability and ensuring rapid adoption across healthcare systems.

Recent Industry Insights

The Bare Metal Stents industry has witnessed transformative shifts over the past 18 months, driven by innovation and strategic realignments. Notably, partnerships have surged as key players collaborate with startups to accelerate R&D in drug-eluting stent hybrids. Regulatory changes, particularly in the EU and U.S., have tightened compliance standards for stent biocompatibility, pushing manufacturers to prioritize material science advancements. Meanwhile, a shift in consumer trends toward cost-effective interventions has spurred demand for generic equivalents, challenging proprietary stent dominance. The sector also saw a landmark acquisition, with MedTech Global acquiring NovaStent Solutions to consolidate its foothold in emerging markets. Funding activity remains robust, with over $250 million raised in 2023 by firms leveraging AI-driven stent design technologies. Looking ahead, the Bare Metal Stents industry trends are poised to prioritize sustainability, as seen in the recent launch of eco-friendly manufacturing processes by industry leaders.

Key Developments4 items

Strategic partnerships between stent manufacturers and AI startups to enhance precision in stent placement

Approval of next-gen bare metal stents with reduced restenosis rates in Japan and the EU

Increased investment in 3D-printed stent prototypes, improving customization for complex cases

Expansion of generic stent portfolios in Asia-Pacific to address affordability gaps

Analyst Overview

The Bare Metal Stents market outlook remains cautiously optimistic, driven by steady demand in cost-sensitive regions and specific clinical scenarios where drug-eluting stents are unsuitable. Market attractiveness is moderate, with growth constrained by the dominance of advanced stent technologies but supported by unmet needs in emerging economies. Competitive intensity is fragmented, featuring established players and niche manufacturers, though barriers to entry remain high due to stringent regulatory requirements and R&D complexities. The long-term outlook is stable, with incremental innovations focused on biocompatibility and restenosis reduction shaping the innovation landscape. Demand-supply balance is generally aligned, though localized shortages may arise in markets with underdeveloped distribution networks. Key risks include regulatory shifts, reimbursement challenges, and erosion of market share by drug-coated stents. Strategic differentiation through cost-effectiveness and clinical evidence will be critical for sustaining relevance.

Key Strategic Considerations3 items

Prioritize emerging markets with affordability-driven healthcare systems

Invest in R&D for next-generation BMS with enhanced performance profiles

Strengthen partnerships to navigate regulatory landscapes and improve accessibility

12 items

1. Executive Summary

2. Bare Metal Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bare Metal Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Bare Metal Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Bare Metal Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Bare Metal Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Bare Metal Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Bare Metal Stents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Bare Metal Stents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Bare Metal Stents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Bare Metal Stents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Bare Metal Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bare Metal Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bare Metal Stents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Bare Metal Stents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Bare Metal Stents Market Competition by Key Manufacturers

9.1. Global Bare Metal Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Bare Metal Stents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott Vascular

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biosensors

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B.Braun

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MicroPort

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biotronik

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bare Metal Stents Market

Figure 4: Global Bare Metal Stents Market: Drivers

Figure 5: Global Bare Metal Stents Market: Challenges

Figure 6: Global Bare Metal Stents Market: Trends

Figure 7: Global Bare Metal Stents Market: Opportunity

Figure 8: Global Bare Metal Stents Market: Restraint

Figure 9: Global Bare Metal Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Bare Metal Stents Market Value (USD Million) By Region

Figure 19: Global Bare Metal Stents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Bare Metal Stents Market Value (USD Million) By Region

Figure 27: Global Bare Metal Stents Market Share (%) By: Regions (2032)

Figure 28: Global Bare Metal Stents Market Volume (K) By Region

Figure 29: Global Bare Metal Stents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Bare Metal Stents Market Value (USD Million) By Region

Figure 37: Global Bare Metal Stents Market Share (%) By: Regions (2032)

Figure 38: Global Bare Metal Stents Market Volume (K) By Region

Figure 39: Global Bare Metal Stents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Bare Metal Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bare Metal Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bare Metal Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Bare Metal Stents Market Value (USD Million) By Region

Table 14: Global Bare Metal Stents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Bare Metal Stents Market Volume (K) By Region

Table 31: Global Bare Metal Stents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Bare Metal Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Bare Metal Stents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Bare Metal Stents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Vascular Basic Information And Sales Area

Table 52: Abbott Vascular. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Terumo Basic Information And Sales Area

Table 58: Terumo. Products Portfolio

Table 59: Biosensors Basic Information And Sales Area

Table 60: Biosensors. Products Portfolio

Table 61: B.Braun Basic Information And Sales Area

Table 62: B.Braun. Products Portfolio

Table 63: MicroPort Basic Information And Sales Area

Table 64: MicroPort. Products Portfolio

Table 65: Biotronik Basic Information And Sales Area

Table 66: Biotronik. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Bare Metal Stents Market Value (USD Million) By Region

Table 76: Global Bare Metal Stents Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Bare Metal Stents Market Volume (K) By Region

Table 93: Global Bare Metal Stents Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Bare Metal Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	623.10 million
Revenue forecast in 2033	1.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular; Medtronic; Boston Scientific; Terumo; Biosensors; B.Braun; MicroPort; Biotronik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Bare Metal Stents Segmentation Breakdown7 items

Application

For Large Vessel (Greater Than or Equal 3mm)

For Small Vessel (Less Than 3mm)

Types

Co-Cr Stent

Pt-Cr Stent

Others

Regional Insights

Loading chart…

Competitive Landscape

Abbott Vascular: Premium pricing and expanded product portfolio for advanced stent solutions

Medtronic: Vertical integration and strategic OEM partnerships to secure raw material supply

Boston Scientific: R&D-driven innovation pipeline targeting small vessel stent markets

Terumo: Regional expansion in Asia-Pacific through localized manufacturing hubs

Biosensors: Cost-effective, commodity-focused stents for high-volume emerging markets

MicroPort: Leveraging China-based production for rapid market penetration in Asia

Key Bare Metal Stents Companies8 items

Abbott Vascular

Medtronic

Boston Scientific

Terumo

Biosensors

B.Braun

MicroPort

Biotronik

Market Ecosystem

Raw material suppliers — provide metals (e.g., stainless steel, cobalt-chromium) and biocompatible coatings for stent fabrication

OEMs/Manufacturers — design and produce bare metal stents, ensuring compliance with regulatory standards

Technology providers — develop proprietary stent delivery systems and imaging compatibility solutions

System integrators — assemble stents with ancillary devices for procedural use (e.g., catheters, guidewires)

Distributors/Channel partners — facilitate product access to hospitals and cardiology centers through sales networks

Service providers — offer post-market technical support, training, and device maintenance services

Regulators/Standards bodies — enforce safety and efficacy requirements for device approval and market clearance

Recent Industry Insights

Key Developments4 items

Strategic partnerships between stent manufacturers and AI startups to enhance precision in stent placement

Approval of next-gen bare metal stents with reduced restenosis rates in Japan and the EU

Increased investment in 3D-printed stent prototypes, improving customization for complex cases

Expansion of generic stent portfolios in Asia-Pacific to address affordability gaps

Analyst Overview

Key Strategic Considerations3 items

Prioritize emerging markets with affordability-driven healthcare systems

Invest in R&D for next-generation BMS with enhanced performance profiles

Strengthen partnerships to navigate regulatory landscapes and improve accessibility

Table of Contents